Immunoprecise Antibodies Ltd IPA

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

[PressRelease]

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce significant insider activity, with key members of its executive team and subsidiary co-founders demonstrating confidence in the Company’s...read article.

[PressRelease]

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The...read article.

[Jonathon Brown]

The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities. read article.

[PressRelease]

Delivers $6.1 Million Q2 Revenue and Announces Strategic Plan to Reshape Biotech and AI-Driven Drug Discovery IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today reported financial results for the second...read article.

[PressRelease]

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced it will be presenting at The Benchmark Company’s 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024,...read article.

[wallpaper2]

They say they take questions but thats an Orchestrated circus. HC Wainwrights Mr Alphabet R is our analyst/rep and he thinks our lab is in Vancouver wtf

[whytestocks]

News; $IPA IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024The Company to host an earnings conference call via webcast IPA

[AxeCap]

I mean why not right?  Desperate times...

[PressRelease]

The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent...read article.

[wallpaper2]

I get one for you. LTNC. Smart.  OTC listing.Just what you like...huge upside, pumpable, good volume etc.  Not a Pot or Weed drink but a Hydrogen drink (all natural.) You can create any

[wallpaper2]

Not a pump and I haven't lost a dime.  Don't touch it, just keep it on your watchlist. 

[dart321]

LOL, yup and far to deep for everyone else, my god man you lost almost everything over this pump give it up and move on, life is to short to dwell on bs pumps. We all make mistakes but you don't

[wallpaper2]

This stock is far too deep for your simple mind. Go back to your Molecule MLCL and try to get it over a penny lol

[dart321]

or is it days away from the pinl sheets? Or is it a total de-listing within days ot weeks? The pump is over wallyworld. How much did you drop?????

[PressRelease]

Innovative Antibodies Show Promise for Antibody-Drug Conjugate (ADC) Development, Paving the Way for Transformative Cancer Treatments ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), a leader in AI-driven medical innovation, is proud to announce a significant breakthrough in...read article.

[PressRelease]

ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA),an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, November 15, 2024, from 9:00 a.m. to 12:30 p.m. EST in Cambridge, Massachusetts. This exclusive...read article.